“…Also yet to be elucidated are the mechanisms underlying the associations between adipose tissue, oestrogen exposure, and brain characteristics, which are likely multifactorial and interactive. Factors such as elevated inflammatory markers have been associated with increased adipose tissue levels ( Aguilar-Valles et al, 2015 , Miller and Spencer, 2014 ), even specifically during the menopause transition ( Lee et al, 2009 ), as well as decreasing oestrogens ( McCarthy and Raval, 2020 ), brain atrophy ( Luo et al, 2022 ), and dementia risk ( Heneka et al, 2015 , Ransohoff, 2016 ). Biological markers of obesity, such as lipid profile ( Anstey et al, 2017 , Reitz, 2012 ), glucose ( Crane et al, 2013 ), HbA1c ( Ramirez et al, 2015 ), leptin ( Zeki Al Hazzouri et al, 2013 ), and Vitamin B12 ( Lauer et al, 2022 ), may also influence associations between adipose tissue and brain health, and contribute to risk of comorbidities such as type II diabetes and hypertension, which are known to impact neural and cardiometabolic health ( Cole, 2020 , Fuchs and Whelton, 2020 , Newby et al, 2022 , Peters et al, 2014 ).…”